Biocompatibles Share Discussion Threads

[aim_trader] 26/1/2009 11:55

"Monday, January 26, 2009
Biocompatibles - cash rich and armed with a strong development pipeline

Biocompatibles, a main board listed medical company, released a trading statement last week, and the numbers were nothing short of excellent. "

[plutonian] 16/1/2009 17:01

The shows revenue up 95% and cash ahead of expectations.

The 5p dividend in May has been planned for a long time and reported regularly. It is being set up to distribute a part of the royalty income from the Medtronic stent. I understand that this is the start of an annual dividend policy.

I agree that the company is undervalued and I do not expect "an instant rise" any time soon. However, it does look like a solid investment for the more patient investor.

[6lucky] 16/1/2009 13:48

Ianwc
Pays a div.
where did you get this info. from ?
Although it has cash and is undervalued I do feel
it is a great co.
Then again there are so many co.s that are undrevalued
It is hard to choose which can give an instant rise.

[ianwc] 16/1/2009 13:34

I am amazed there isn't more investors following this storty. This company has revenues, pays a dividend, buckloads of cash and plenty of promising products in the pipeline.

[plutonian] 23/12/2008 11:03

Some excellent deals negotiated for CellMed...

The by Merz looks like good progress towards the 2009 (?) launch of the product. It is good to see Merz put up the capital for the manufacturing capacity.

Also the recent news that is a good model for funding the pre-clinical studies - no financial outlay and the potential for huge rewards if successful (but, that is a long way away).

[plutonian] 02/12/2008 16:36

Yes, this can go in an ISA. It is listed on the main market.

[hyper al] 02/12/2008 15:07

Can this one go in an iSA

[plutonian] 02/12/2008 14:48

Some recent news that has not been on an RNS...

[plutonian] 02/12/2008 14:07

is promising, but there is a long way to go with this.

I think the recent news that is more significant because "Biocompatibles expects that a positive trial result would establish the combined therapy as the standard of care in the developed world for HCC patients eligible for TACE"

More recently the shows everything is going to plan.

[scribbler101] 31/10/2008 09:53

TRATANTE - i SOLD OUT AGES AGO - JUST STILL GOT ON MY FAVES LIST.

[plutonian] 29/10/2008 17:08

The high court has approved the cancellation of the share premium account, so the 5p dividend in May can now be paid.

[tratante] 21/10/2008 17:18

Scribbler - thanks. It would be good to see this benefit from the bounce, but as you say it's lightly traded so guess it doesn't get much momentum behind it. Had a quite a bit of ground to make up even before the crash.

[scribbler101] 21/10/2008 17:08

trat - that happens with lightly traded stocks in volatile markets. The 117 is last traded, but the quotes have moved higher. Quote will revert to mid-mkt at close.

[tratante] 21/10/2008 11:46

Anyone know what's going on here? Sp given as 117, but the bid is shown as 119 and offer 128. Tempted by a few more of these, price still a bargain, but puzzled by these numbers. Would like to see them begin to move up.

[tratante] 14/10/2008 11:01

These are valued at the company's cash pile - nothing for the business at all at this price.

[waughl] 29/8/2008 10:12

Its a bit frustrating at IG where they haven't posted the Precision V results OR the interim results... i even called them to give them a heads up.. still no news today..

[plutonian] 28/8/2008 12:03

Yes, the show steady progress and give good guidance for future growth.

[waughl] 28/8/2008 07:59

half year results look pretty good, would expect some improvement in share price today,.

[plutonian] 15/8/2008 11:01

are positive, but primary end point of improved tumour response is not statistically significant. The lower toxicity looks to be the more important result.

[plutonian] 31/7/2008 17:35

I think it is recovery from a stupid level to an undervalued level so far, but recent strength in a horrible general market is welcome.

[tratante] 31/7/2008 16:35

Hopefully this is beginning to achieve its true value - I hope I am not speaking too soon!

[plutonian] 31/7/2008 15:38

Welcome to , who brings useful clinical research experience in oncology.

[plutonian] 26/7/2008 17:04

The looks like a good fit:Cash generative
Complementary technology
US presence

[tratante] 30/5/2008 17:20

Yes there was a buy recommendation in today's issue -should have made that clear.

I don't subscribe, just skim in WHS, but they reitterated their original buy at 143 (presumably that's the same one you refer to from beginning of the year) at current price. Said there was plenty of upside, highlighted the various income streams (might even have got it from your post above!) and quoted the Piper Jaffrey target - can't recall a date attached.

I agree about it being nice without all the traders; looking at some of the boards it seems some people must lead rather dull lives, but nevertheless it surprises me that there is so little interest in BII.